ALL CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID ETHYL ESTER
ALL CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID ETHYL ESTER Basic information
- Product Name:
- ALL CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID ETHYL ESTER
- Synonyms:
-
- ALL CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID ETHYL ESTER
- ALL CIS 7-10-13-16-19 DPA ETHYL ESTER
- ETHYL ALL CIS-7,10,13,16,19-DOCOSAPENTAENOATE
- DPA ETHYL ESTER
- (All-Z)-7,10,13,16,19-Docosapentaenoic Acid Ethyl Ester
- all cis-7,10,13,16,19-Docosapentaenoic Acid Ethyl Ester DPA Ethyl Ester
- Ethyl all cis-7,10,13,16,19-Docosapentaenoate
- (7Z,10Z,13Z,16Z,19Z)-Ethyl docosa-7,10,13,16,19-pentaenoate
- CAS:
- 119818-40-5
- MF:
- C24H38O2
- MW:
- 358.56
- Product Categories:
-
- Biochemistry
- Higher Fatty Acids & Higher Alcohols
- Unsaturated Higher Fatty Acid Esters
- Mol File:
- 119818-40-5.mol
ALL CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID ETHYL ESTER Chemical Properties
- refractive index
- 1.4840-1.4880
- storage temp.
- Freezer
- solubility
- Chloroform (Slightly), Methanol (Slightly)
- form
- Oil
- color
- Colourless to Pale Yellow
ALL CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID ETHYL ESTER Usage And Synthesis
Description
Docosapentaenoic acid ethyl ester is a derivative of DPA , an ω-3 fatty acid found in fish oils. Ethyl ester derivatives of fatty acids, including DPA, are often used in formulations designed as dietary supplements.
Uses
(All-Z)-7,10,13,16,19-Docosapentaenoic Acid Ethyl Ester is used in analytical studies for the detection of fish oil ethyl ester concentration via gas chromatography. This analog is an ethyl derivative of all-cis-7,10,13,16,19-Docosapentaenoic Acid (D494460) which is a fatty acid that is derived from fish oils which potently inhibits platelet aggregation.
Definition
ChEBI: Ethyl (7Z,10Z,13Z,16Z,19Z)-docosapentaenoate is a long-chain fatty acid ethyl ester resulting from the formal condensation of the carboxy group of (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid with the hydroxy group of ethanol. It is functionally related to a (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid.
References
[1] MICHAEL J JAMES Leslie G C Virginia M Ursin. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n?3 fatty acids12[J]. American Journal of Clinical Nutrition, 2003, 77 5: Pages 1140-1145. DOI: 10.1093/ajcn/77.5.1140
[2] ALICIA H. AUGUSTINE . Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance[J]. Prostaglandins, leukotrienes, and essential fatty acids, 2014, 90 2: Pages 69-75. DOI: 10.1016/j.plefa.2013.12.003
[3] JAMES BACKES. The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia.[J]. Lipids in Health and Disease, 2016, 15 1: 118. DOI: 10.1186/s12944-016-0286-4
ALL CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID ETHYL ESTERSupplier
- Tel
- 13761144602
- 3896578657@qq.com
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 4006356688 18621169109
- market03@meryer.com
- Tel
- 021-67121386
- Sales-CN@TCIchemicals.com
- Tel
- 021-021-58432009 400-005-6266
- sales8178@energy-chemical.com